Top ▲
Target not currently curated in GtoImmuPdb
Target id: 466
Nomenclature: nicotinic acetylcholine receptor α5 subunit
Gene and Protein Information | ||||||
Species | TM | AA | Chromosomal Location | Gene Symbol | Gene Name | Reference |
Human | 4 | 468 | 15q25.1 | CHRNA5 | cholinergic receptor nicotinic alpha 5 subunit | 4 |
Mouse | 4 | 467 | 9 29.84 cM | Chrna5 | cholinergic receptor, nicotinic, alpha polypeptide 5 | 4 |
Rat | 4 | 452 | 8q24 | Chrna5 | cholinergic receptor nicotinic alpha 5 subunit | 2 |
Database Links | |
Alphafold | P30532 (Hs), Q2MKA5 (Mm), P20420 (Rn) |
CATH/Gene3D | 2.70.170.10 |
ChEMBL Target | CHEMBL3038461 (Hs), CHEMBL3137272 (Hs), CHEMBL3137273 (Hs), CHEMBL3350222 (Mm), CHEMBL4106146 (Rn) |
Ensembl Gene | ENSG00000169684 (Hs), ENSMUSG00000035594 (Mm), ENSRNOG00000013610 (Rn) |
Entrez Gene | 1138 (Hs), 110835 (Mm), 25102 (Rn) |
Human Protein Atlas | ENSG00000169684 (Hs) |
KEGG Gene | hsa:1138 (Hs), mmu:110835 (Mm), rno:25102 (Rn) |
OMIM | 118505 (Hs) |
Pharos | P30532 (Hs) |
RefSeq Nucleotide | NM_000745 (Hs), NM_176844 (Mm), NM_017078 (Rn) |
RefSeq Protein | NP_000736 (Hs), NP_789814 (Mm), NP_058774 (Rn) |
UniProtKB | P30532 (Hs), Q2MKA5 (Mm), P20420 (Rn) |
Wikipedia | CHRNA5 (Hs) |
Natural/Endogenous Ligands |
acetylcholine |
Download all structure-activity data for this target as a CSV file
Antagonists | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | View all chemical structures | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Tissue Distribution | ||||||||
|
||||||||
|
||||||||
|
Physiological Consequences of Altering Gene Expression | ||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
||||||||||
|
Clinically-Relevant Mutations and Pathophysiology | ||||||||||||||||||||||||||||
|
1. Bailey CD, De Biasi M, Fletcher PJ, Lambe EK. (2010) The nicotinic acetylcholine receptor alpha5 subunit plays a key role in attention circuitry and accuracy. J Neurosci, 30 (27): 9241-52. [PMID:20610759]
2. Boulter J, O'Shea-Greenfield A, Duvoisin RM, Connolly JG, Wada E, Jensen A, Gardner PD, Ballivet M, Deneris ES, McKinnon D et al.. (1990) Alpha 3, alpha 5, and beta 4: three members of the rat neuronal nicotinic acetylcholine receptor-related gene family form a gene cluster. J Biol Chem, 265 (8): 4472-82. [PMID:1689727]
3. Brown RW, Collins AC, Lindstrom JM, Whiteaker P. (2007) Nicotinic alpha5 subunit deletion locally reduces high-affinity agonist activation without altering nicotinic receptor numbers. J Neurochem, 103 (1): 204-15. [PMID:17573823]
4. Eng CM, Kozak CA, Beaudet AL, Zoghbi HY. (1991) Mapping of multiple subunits of the neuronal nicotinic acetylcholine receptor to chromosome 15 in man and chromosome 9 in mouse. Genomics, 9 (2): 278-82. [PMID:2004777]
5. Fischer H, Orr-Urtreger A, Role LW, Huck S. (2005) Selective deletion of the alpha5 subunit differentially affects somatic-dendritic versus axonally targeted nicotinic ACh receptors in mouse. J Physiol (Lond.), 563 (Pt 1): 119-37. [PMID:15611037]
6. Fowler CD, Lu Q, Johnson PM, Marks MJ, Kenny PJ. (2011) Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature, 471 (7340): 597-601. [PMID:21278726]
7. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P et al.. (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 452 (7187): 633-7. [PMID:18385738]
8. Improgo MR, Scofield MD, Tapper AR, Gardner PD. (2010) The nicotinic acetylcholine receptor CHRNA5/A3/B4 gene cluster: dual role in nicotine addiction and lung cancer. Prog Neurobiol, 92 (2): 212-26. [PMID:20685379]
9. Jackson KJ, Marks MJ, Vann RE, Chen X, Gamage TF, Warner JA, Damaj MI. (2010) Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. J Pharmacol Exp Ther, 334 (1): 137-46. [PMID:20400469]
10. Kuryatov A, Berrettini W, Lindstrom J. (2011) Acetylcholine receptor (AChR) α5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (α4β2)₂α5 AChR function. Mol Pharmacol, 79 (1): 119-25. [PMID:20881005]
11. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, Heinemann SF, Collins AC. (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci, 12 (7): 2765-84. [PMID:1613557]
12. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau O et al.. (2007) Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet, 16 (1): 36-49. [PMID:17135278]
13. Salas R, Orr-Urtreger A, Broide RS, Beaudet A, Paylor R, De Biasi M. (2003) The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo. Mol Pharmacol, 63 (5): 1059-66. [PMID:12695534]
14. Wada E, McKinnon D, Heinemann S, Patrick J, Swanson LW. (1990) The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (alpha 5) in the rat central nervous system. Brain Res, 526 (1): 45-53. [PMID:2078817]
15. Wang N, Orr-Urtreger A, Chapman J, Rabinowitz R, Korczyn AD. (2004) Nicotinic acetylcholine receptor alpha5 subunits modulate oxotremorine-induced salivation and tremor. J Neurol Sci, 222 (1-2): 87-91. [PMID:15240201]
16. Wang N, Orr-Urtreger A, Chapman J, Rabinowitz R, Nachman R, Korczyn AD. (2002) Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit. J Physiol (Lond.), 542 (Pt 2): 347-54. [PMID:12122136]